124 related articles for article (PubMed ID: 38019008)
1. Anticipated Versus Unanticipated Incomplete Mohs Micrographic Surgery for Keratinocyte Carcinomas: Impact on Treatment Delays and Final Margin Status.
Lin SK; Deitermann AM; Lubeck M; Veerabagu S; Cheng B; Miller CJ; Etzkorn J; Sobanko JF; Shin TM; Higgins HW; Giordano CN; Walker JL; Zhang J; Nguyen HP; McMurray SL
Dermatol Surg; 2023 Dec; 49(12):1066-1071. PubMed ID: 38019008
[TBL] [Abstract][Full Text] [Related]
2. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
Cerci FB; Kubo EM; Werner B; Tolkachjov SN
J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery.
Ratner D; Bagiella E
Dermatol Surg; 2003 Sep; 29(9):899-903. PubMed ID: 12930329
[TBL] [Abstract][Full Text] [Related]
4. Margin Reanalysis With 3-Dimensional Micrographic Surgery Technique of Conventional Excision Specimens With Negative Margin Readings.
Magliano J; Navarrete J; Lezue V; González A; Martínez M; Bazzano C
Am J Dermatopathol; 2021 Jul; 43(7):485-488. PubMed ID: 32956098
[TBL] [Abstract][Full Text] [Related]
5. Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery.
Schell AE; Russell MA; Park SS
JAMA Facial Plast Surg; 2013; 15(5):337-43. PubMed ID: 23744451
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous intraoperative Mohs clearance and reconstruction for advanced cutaneous malignancies.
Seth R; Revenaugh PC; Vidimos AT; Scharpf J; Somani AK; Fritz MA
Arch Facial Plast Surg; 2011; 13(6):404-10. PubMed ID: 22106186
[TBL] [Abstract][Full Text] [Related]
7. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.
Lane JE; Kent DE
Curr Surg; 2005; 62(5):518-26. PubMed ID: 16125611
[TBL] [Abstract][Full Text] [Related]
8. Dermoscopy prior to Mohs micrographic surgery does not improve tumour margin assessment and leads to fewer Mohs stages.
Jayasekera PSA; Dodd J; Oliphant T; Langtry JAA; Lawrence CM
Br J Dermatol; 2018 Feb; 178(2):565-566. PubMed ID: 28851098
[No Abstract] [Full Text] [Related]
9. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
10. [Mohs micrographic surgery for repeat excision of basal cell carcinomas on the head with positive margins].
Angulo J; Serra-Guillén C; Traves V; Botella-Estrada R; Sanmartín O; Llombart B; Requena C; Guillén C; Nagore E
Actas Dermosifiliogr; 2011 Dec; 102(10):797-804. PubMed ID: 21684507
[TBL] [Abstract][Full Text] [Related]
11. Melanomas of the head and neck have high-local recurrence risk features and require tissue-rearranging reconstruction more commonly than basal cell carcinoma and squamous cell carcinoma: A comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors.
Fix W; Etzkorn JR; Shin TM; Howe N; Bhatt M; Sobanko JF; Miller CJ
J Am Acad Dermatol; 2021 Aug; 85(2):409-418. PubMed ID: 30458206
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Factors Influencing Resection Margin Involvement During Mohs Micrographic Surgery for Skin Tumors.
Chu J; Chung Y; Chae SW; Choi YJ; Kim HS; DO SI
Anticancer Res; 2023 Jun; 43(6):2707-2715. PubMed ID: 37247935
[TBL] [Abstract][Full Text] [Related]
13. Curettage prior to Mohs' micrographic surgery for previously biopsied nonmelanoma skin cancers: what are we curetting? Retrospective, prospective, and comparative study.
Jih MH; Friedman PM; Goldberg LH; Kimyai-Asadi A
Dermatol Surg; 2005 Jan; 31(1):10-5. PubMed ID: 15720088
[TBL] [Abstract][Full Text] [Related]
14. Post-Mohs micrographic surgical margin tissue evaluation with permanent histopathologic sections.
Campbell RM; Barrall D; Wilkel C; Robinson-Bostom L; Dufresne RG
Dermatol Surg; 2005 Jun; 31(6):655-8; discussion 658. PubMed ID: 15996415
[TBL] [Abstract][Full Text] [Related]
15. Mohs Micrographic Surgery for Primary Versus Recurrent or Incompletely Excised Facial High-risk Basal Cell Carcinomas.
Ceder H; Grönberg M; Paoli J
Acta Derm Venereol; 2021 Feb; 101(2):adv00381. PubMed ID: 33205823
[TBL] [Abstract][Full Text] [Related]
16. Synoptic reporting in Mohs micrographic surgery.
Cabrera S; Smith S; Ryman W
Australas J Dermatol; 2020 Feb; 61(1):43-45. PubMed ID: 31429917
[TBL] [Abstract][Full Text] [Related]
17. Reliability of skin biopsies in determining accurate tumor margins: a retrospective study after Mohs micrographic surgery.
Koslosky CL; El Tal AK; Workman B; Tamim H; Durance MC; Mehregan DA
Dermatol Surg; 2014 Sep; 40(9):964-70. PubMed ID: 25099294
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
Spraul CW; Ahr WM; Lang GK
Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
[TBL] [Abstract][Full Text] [Related]
19. Potential utility of adjunctive histopathologic evaluation of some tumors treated by Mohs micrographic surgery.
Weisberg NK; Becker DS
Dermatol Surg; 2000 Nov; 26(11):1052-6. PubMed ID: 11096394
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas.
Kimyai-Asadi A; Alam M; Goldberg LH; Peterson SR; Silapunt S; Jih MH
J Am Acad Dermatol; 2005 Sep; 53(3):464-8. PubMed ID: 16112354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
